Association of Glycemic Status with Disability, Relapse Activity, Inflammatory Markers, and Metabolic Profile in Patients with Multiple Sclerosis
Journal of Clinical Medicine · 30.07.2026 · 15 (15) · 5960
DOI: 10.3390/jcm15155960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.07.2026. Verfasst von Soner Yeşilyurt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Taksim Training and Research Hospital, University of Health Sciences, Istanbul 34764, Türkiye. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Metabolic dysregulation has emerged as a potential modifier of disease activity and disability in multiple sclerosis (MS). However, the relationship between glycemic status and clinical outcomes in patients with MS remains incompletely understood. This study aimed to investigate the associations of glycemic regulation with disease severity, relapse activity, inflammatory markers, and metabolic characteristics in patients with MS.
Methods
In this retrospective single-center observational study, 455 patients with MS aged 18–65 years were included. Patients were categorized into normoglycemia (n = 241), prediabetes (n = 98), and diabetes (n = 116) according to American Diabetes Association criteria and documented diabetes diagnosis. Demographic characteristics, Expanded Disability Status Scale (EDSS) scores, annualized relapse rate (ARR), disease-modifying therapy (DMT), hematological indices, inflammatory markers, and metabolic parameters were retrieved from electronic medical records. Associations between glycemic status and clinical outcomes were evaluated using group comparisons, Spearman correlation analyses, and multivariable linear regression models.
Results
Significant differences were observed among glycemic groups for age, disease duration, EDSS score, ARR, MS phenotype, platelet count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), lipid parameters, estimated glomerular filtration rate, alanine aminotransferase, gamma-glutamyl transferase, triglyceride–glucose (TyG) index, and atherogenic index of plasma (all p < 0.05). HbA1c, FPG, TyG index, lipid parameters, CRP, and ESR were positively correlated with EDSS scores (all p < 0.05). In contrast, these markers showed inverse correlations with ARR. However, after adjustment for demographic and clinical variables, including age, sex, disease duration, MS phenotype, and disease-modifying therapy (DMT), neither prediabetes nor diabetes remained independently associated with disability, as measured by the EDSS score, or with ARR. Progressive MS phenotype, older age, and longer disease duration were independently associated with higher disability, whereas age, disease duration, and progressive phenotype were independently associated with lower ARR.
Conclusions
Impaired glycemic status is associated with greater disability, unfavorable metabolic profiles, and increased systemic inflammation in patients with MS. Nevertheless, glycemic status was not independently associated with disability or relapse activity after adjustment for major clinical confounders. These findings suggest that metabolic dysregulation accompanies more severe clinical characteristics but may not independently drive disease progression in MS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Taksim Training and Research Hospital, University of Health Sciences, Istanbul 34764, Türkiye.
- Department of Neurology, Taksim Training and Research Hospital, University of Health Sciences, Istanbul 34433, Türkiye.
- Department of Internal Medicine, Ümraniye Training and Research Hospital, University of Health Sciences, Istanbul 34764, Türkiye.
- Department of Biochemistry, Faculty of Medicine, Istanbul Atlas University, Istanbul 34408, Türkiye.
ORCID-Profile: Soner Yeşilyurt, Mehmet Tayfur
Zitieren
APA
Yeşilyurt, S., Tokdemir, F. T., Tayfur, M., Altunrende, B., & Uzun, H. (2026). Association of Glycemic Status with Disability, Relapse Activity, Inflammatory Markers, and Metabolic Profile in Patients with Multiple Sclerosis. Journal of Clinical Medicine, 15(15), 5960. https://doi.org/10.3390/jcm15155960
Vancouver
Yeşilyurt S, Tokdemir FT, Tayfur M, Altunrende B, Uzun H. Association of Glycemic Status with Disability, Relapse Activity, Inflammatory Markers, and Metabolic Profile in Patients with Multiple Sclerosis. Journal of Clinical Medicine. 2026;15(15):5960. doi:10.3390/jcm15155960
BibTeX
@article{Yeilyurt2026,
author = {Yeşilyurt, Soner and Tokdemir, Furkan Talha and Tayfur, Mehmet and Altunrende, Burcu and Uzun, Hafize},
title = {Association of Glycemic Status with Disability, Relapse Activity, Inflammatory Markers, and Metabolic Profile in Patients with Multiple Sclerosis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {5960},
doi = {10.3390/jcm15155960}
}
EUVIMED